CAS NO: | 2375193-43-2 |
生物活性 | XRK3F2 is an inhibitor ofp62 (Sequestosome-1)-ZZ/domain. | ||||||||||||||||
IC50& Target | P62-ZZ domain[1]. | ||||||||||||||||
体外研究 (In Vitro) | The presence of XRK3F2 during MM-preOB co-cultures prevents Runx2 suppression at both d0 and d4. Furthermore, XRK3F2 blocks MM-induced upregulation ofGfi1. XRK3F2 blocks the induction ofGfi1mRNA in BMSC in both treatment conditions. In contrast, XRK3F2 prevents both MM1.S CM and TNFα plus IL7-mediated Runx2 suppression. Further, the pro-inflammatory and myeloma pro-survival factor IL6 mRNA is also reduced by XRK3F2 treatment. In addition, XRK3F2 also prevents TNFα-mediated upregulation ofGfi1and rescues inhibition ofRunx2in MC4 preOB. XRK3F2 prevents MM-inducedGFI1occupancy at theRunx2-P1 promoter. XRK3F2 treatment significantly rescues the H3K9ac levels at Runx2 in MM patient hBMSC and XRK3F2 can rescue early steps in osteogenesis[1]. | ||||||||||||||||
分子量 | 435.89 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C23H24ClF2NO3 | ||||||||||||||||
CAS 号 | 2375193-43-2 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | 4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) | ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 150 mg/mL(344.12 mM;Need ultrasonic) H2O : 0.91 mg/mL(2.09 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024 |